Saquinavir labels and packages: Difference between revisions
| Line 4: | Line 4: | ||
==Labels And Packages== | ==Labels And Packages== | ||
= | |||
===PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label=== | |||
NDC 0004-0244-51 | NDC 0004-0244-51 | ||
| Line 35: | Line 35: | ||
|} | |} | ||
===PRINCIPAL DISPLAY PANEL - 200 mg Bottle Label=== | |||
NDC 0004-0245-15 | NDC 0004-0245-15 | ||
Latest revision as of 17:05, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
=
PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label
NDC 0004-0244-51
Invirase® (saquinavir mesylate) Tablets
500 mg
Each tablet contains saquinavir mesylate equivalent to 500 mg saquinavir (free base).
Rx only
ALERT: Find out about medicines that should NOT be taken with INVIRASE.
Attention Pharmacist: Dispense the attached Medication Guide to each patient. Do not cover ALERT box with pharmacy label.
120 tablets
Genentech
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 200 mg Bottle Label
NDC 0004-0245-15
Invirase® (saquinavir mesylate) Capsules
200 mg
Each capsule contains saquinavir mesylate equivalent to 200 mg saquinavir (free base).
Rx only
ALERT: Find out about medicines that should NOT be taken with INVIRASE.
Attention Pharmacist: Dispense the attached Medication Guide to each patient. Do not cover ALERT box with pharmacy label.
270 capsules
Genentech[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.